Dyne Therapeutics, Inc. · NASDAQ:DYN
Lucera Erick sold 2,362 Dyne Therapeutics, Inc. shares (Form 4)
Traded Jun 25, 2026 · Filed Jun 26, 2026
On Jun 25, 2026, Lucera Erick (Chief Financial Officer) sold 2,362 Dyne Therapeutics, Inc. shares at US$20.37 for US$48,114, leaving 121,563 shares. Filed Jun 26, 2026 (Form 4).
- Sold
- 2,362 shares
- Price
- US$20.37
- Value
- US$48,114
- Holding after
- 121,563 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Common Stock | Sale | 2,362 | US$20.37 | 121,563 | Direct |
Source
Related
- Dyne Therapeutics, Inc.
- Lucera Erick
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Lucera Erick · Aug 17, 2026
- Form 4 · Lucera Erick · May 14, 2026
- Form 4 · Lucera Erick · Apr 3, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026